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COMMENTARY
Body mass index, type 2 diabetes, 
and left ventricular function
Katrine Dina Musaeus1 and Manan Pareek2,3* 
Abstract 
A recent study found that among individuals with a preserved left ventricular ejection fraction ≥ 55%, global longi-
tudinal strain was significantly lower in overweight patients (i.e., body mass index ≥ 25 kg/m2) with, but not in those 
without, type 2 diabetes mellitus. These results contrast previous observations of body mass index as a significant pre-
dictor of incident diastolic dysfunction and increased left ventricular mass index among subjects without prevalent 
diabetes. We discuss potential explanations for the observed discrepancies and general difficulties associated with 
cardiovascular risk assessment based on body mass index and related metabolic factors.
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To the Editor
We have read with great interest the study by Suto et al. 
on how overweight might affect left ventricular (LV) 
function in subjects with and without type 2 diabetes 
mellitus (T2DM) [1]. The authors evaluated 145 patients 
with T2DM and 90 healthy controls, matched on age, 
sex, and LV ejection fraction (LVEF). All participants 
had a preserved LVEF (≥  55%). The main finding was 
that global longitudinal strain (GLS) was significantly 
lower among overweight patients (i.e., body mass index 
(BMI) ≥  25  kg/m2) with T2DM, but not among those 
who were overweight without T2DM. It was suggested 
that the development of heart failure with preserved EF 
may be prevented by controlling overweight in patients 
with T2DM. We believe that this study warrants further 
discussion.
The results contrast previous observations of BMI as 
a significant predictor of incident diastolic dysfunction 
and increased LV mass index among subjects without 
diabetes at baseline [2]. Although GLS cannot be directly 
compared with traditional Doppler markers of diastolic 
function, one possible explanation for the discrepant 
findings may lie in the suboptimal utilization of BMI data 
in both studies. Indeed, given its J- or U-shaped associa-
tion with clinical endpoints, BMI is too complex a vari-
able to be used in a simple linear or dichotomized fashion 
[3–6]. Spline functions or fractional polynomial regres-
sion models may be preferable in such settings. As an 
aside, matching individuals on BMI might have enabled 
the investigators to tease out any independent effects of 
T2DM.
Numerically, it may seem as if the presence of over-
weight reduced GLS to a greater extent among patients 
with T2DM as compared with non-diabetics, and this is 
certainly supported by the Cardiovascular Continuum 
concept, by which hyperglycemia accelerates the cardio-
vascular aging process [7]. However, the potential for a 
type 2 error should not be overlooked. Assuming a 1:1 
ratio of overweight versus non-overweight healthy con-
trols, a sample size of 270 would have been sufficient to 
render a significant two-sided P value for the observed 
GLS difference of 0.6, with 80% power. With the same 
power, 200 patients with T2DM would be required to 
show statistical significance at a difference of 1.0. This 
might explain why only a few echocardiographic vari-
ables reached statistically significant differences in 
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Table 2 in the original paper [1]. Accordingly, we encour-
age the authors to provide the results of an appropriate 
interaction analysis to better clarify this issue.
Finally, in the previous study, BMI was independently 
associated with incident echocardiographic abnormali-
ties at the expense of insulin sensitivity [2]. The frequent 
co-occurrence of insulin resistance, hyperinsulinemia, 
obesity, hypertension, and T2DM makes it difficult to 
dissect the separate role of each of these conditions for 
the development of subclinical cardiac damage, and stud-
ies of insulin and cardiac structure and function have 
revealed inconsistent findings [8–10]. Therefore, we 
believe the authors have a golden opportunity to exam-
ine associations between insulin and the most sensitive 
marker of impaired LV function, GLS.
Abbreviations
BMI: body mass index; EF: ejection fraction; GLS: global longitudinal strain; LV: 
left ventricle/left ventricular; LVEF: left ventricular ejection fraction; T2DM: type 
2 diabetes mellitus.
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